BioXcel Therapeutics, Inc. (BTAI) Gross profit 2022–2025
BioXcel Therapeutics, Inc. (BTAI) annual gross profit history from SEC filings — each fiscal year as reported.
$478,000FY2025 · since FY2022: $355,000 → $478,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $478,000 | +288.6% |
| FY2024 | $123,000 | +2.5% |
| FY2023 | $120,000 | -66.2% |
| FY2022 | $355,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice